全文获取类型
收费全文 | 30275篇 |
免费 | 2782篇 |
国内免费 | 72篇 |
专业分类
耳鼻咽喉 | 393篇 |
儿科学 | 985篇 |
妇产科学 | 755篇 |
基础医学 | 4543篇 |
口腔科学 | 562篇 |
临床医学 | 3617篇 |
内科学 | 5908篇 |
皮肤病学 | 562篇 |
神经病学 | 3062篇 |
特种医学 | 761篇 |
外科学 | 3735篇 |
综合类 | 427篇 |
一般理论 | 30篇 |
预防医学 | 3250篇 |
眼科学 | 515篇 |
药学 | 1977篇 |
中国医学 | 38篇 |
肿瘤学 | 2009篇 |
出版年
2023年 | 254篇 |
2022年 | 435篇 |
2021年 | 964篇 |
2020年 | 626篇 |
2019年 | 880篇 |
2018年 | 887篇 |
2017年 | 732篇 |
2016年 | 761篇 |
2015年 | 864篇 |
2014年 | 1077篇 |
2013年 | 1517篇 |
2012年 | 2129篇 |
2011年 | 2118篇 |
2010年 | 1021篇 |
2009年 | 963篇 |
2008年 | 1676篇 |
2007年 | 1682篇 |
2006年 | 1531篇 |
2005年 | 1512篇 |
2004年 | 1427篇 |
2003年 | 1320篇 |
2002年 | 1158篇 |
2001年 | 497篇 |
2000年 | 517篇 |
1999年 | 432篇 |
1998年 | 273篇 |
1997年 | 227篇 |
1996年 | 195篇 |
1995年 | 174篇 |
1994年 | 155篇 |
1993年 | 136篇 |
1992年 | 326篇 |
1991年 | 316篇 |
1990年 | 284篇 |
1989年 | 291篇 |
1988年 | 237篇 |
1987年 | 244篇 |
1986年 | 266篇 |
1985年 | 237篇 |
1984年 | 197篇 |
1983年 | 158篇 |
1982年 | 146篇 |
1979年 | 192篇 |
1978年 | 123篇 |
1977年 | 125篇 |
1975年 | 120篇 |
1974年 | 151篇 |
1973年 | 139篇 |
1972年 | 145篇 |
1971年 | 123篇 |
排序方式: 共有10000条查询结果,搜索用时 578 毫秒
31.
Book reviewed in this articles: Essential Paediatric Dermatology . By J, Verbov Skin Disorders in the Elderly . Edited by B. E. Monk , R. A. C. Graham 相似文献
32.
33.
Sanjay Sisodiya J Helen Cross Ingmar Blümcke David Chadwick John Craig Peter B Crino Paul Debenham Norman Delanty Frances Elmslie Mark Gardiner Jeffrey Golden David Goldstein David A Greenberg Renzo Guerrini Michael Hanna John Harris Paul Harrison Michael R Johnson George Kirov Dimitri M Kullman Andrew Makoff Carla Marini Rima Nabbout Lina Nashef Jeffrey L Noebels Ruth Ottman Munir Pirmohamed Asla Pitk?nen Ingrid Scheffer Simon Shorvon Graeme Sills Nicholas Wood Sameer Zuberi 《Epileptic Disord》2007,9(2):194-236
The Sixth Epilepsy Research Foundation workshop, held in Oxford in March 2006, brought together basic scientists, geneticists, epidemiologists, statisticians, pharmacologists and clinicians to consider progress, issues and strategies for harnessing genetics to improve the understanding and treatment of the epilepsies. General principles were considered, including the fundamental importance of clear study design, adequate patient numbers, defi ned phenotypes, robust statistical data handling, and follow-up of genetic discoveries. Topics where some progress had been made were considered including chromosomal abnormalities, neurodevelopment, hippocampal sclerosis, juvenile myoclonic epilepsy, focal cortical dysplasia and pharmacogenetics. The ethical aspects of epilepsy genetics were reviewed. Principles and limitations of collaboration were discussed. Presentations and their matched discussions are produced here. There was optimism that further genetic research in epilepsy was not only feasible, but might lead to improvements in the lives of people with epilepsy. 相似文献
34.
Douglas Harrison Gennaro Selvaggi 《Journal of plastic, reconstructive & aesthetic surgery》2007,60(8):922-928
The most common surgical techniques performed for gluteal augmentation employ the use of implants and a combination of liposuction/lipo-injection procedures. We review the major literature concerning this subject with emphasis on gluteal implants, the various indications, surgical techniques and complications are discussed and we present some of our cases. Contour reconstruction, indications such as malformation, asymmetry, trauma and radiotherapy may require custom-made or regular implants, liposuction or lipo-injection procedures and sometimes free flaps. Gluteal implants for aesthetic purposes are widely used, particularly in South America, are easy to perform with a high success rate, whereas lipS200osuction and lipo-injection procedures require considerable experience in Coleman fat injection. 相似文献
35.
36.
37.
Ruth McDonald BA MSc PhD Stephen Harrison BSc MPhil PhD 《Health & social care in the community》2004,12(3):194-201
Recent New Labour policy for the ‘modernisation’ of Government places a good deal of emphasis on decentralisation. This emphasis is particularly marked in relation to the organisation of primary care. However, like hospitals and other National Health Service institutions, primary care trusts (PCTs) are subject to a substantial raft of centrally established performance targets and indicators, including those which contribute to the public award of between zero and three performance ‘stars’. This raises questions about the extent to which employees can exercise autonomy in the context of rigid top‐down directives. This paper presents findings from a study using participant observation and interviews to examine the impact of a training course aimed ostensibly at increasing employee autonomy in an English PCT. The suggestion is that attempts to make employees more autonomous can be seen as a strategy for increasing central control based upon the internalisation by the employees of centrally promulgated values. The attraction of such strategies is that they may be potentially more effective and less costly than alternative strategies of direct control. However, the study suggests that the outcome of attempts by such methods as programmes to increase employee autonomy may be very different from those intended. 相似文献
38.
Patient experience with, and use of, an electronic monitoring system to assess vaccination responses
Stuart S. Olmsted PhD John D. Grabenstein RPh PhD † Arvind K. Jain MS ‡ Nicole Lurie MD MSPH § 《Health expectations》2006,9(2):110-117
OBJECTIVE: To evaluate the user experience and acceptability of an electronic patient monitoring system. SETTING AND PARTICIPANTS: 822 Military and civilian personnel at a health clinic at a major US military headquarters used an Internet and telephone-based electronic monitoring system to report vaccination-site responses and symptoms after receiving the smallpox vaccination. Focus groups of vaccinees were conducted to help develop a survey about the experience that was distributed to 379 vaccinees (96% completion rate). RESULTS: Users of the electronic monitoring system reported that it was fast and easy to use and reported they would use a system like this again and recommend an electronic monitoring system to a friend or relative. Most users (84%) were comfortable with a physician tracking their vaccine reaction using their electronic reports, but only half (51%) were comfortable with eliminating the post-vaccination follow-up visit with their health-care provider based on their electronic reports. CONCLUSIONS: This electronic monitoring system was well received by vaccinees and allowed health-care providers to track the status of vaccinees. However, vaccinees were not comfortable replacing a physician visit with electronic monitoring, at least for the smallpox vaccination. A monitoring system like this may be useful in public health settings, such as mass vaccination or prophylaxis during a bioterrorism event, a pandemic influenza outbreak, or another public health emergency. 相似文献
39.
40.
A T Farrell I Papadouli A Hori M Harczy B Harrison W Asakura M Marty R Dagher R Pazdur 《Annals of oncology》2006,17(6):889-896
PURPOSE: This paper summarizes the role of external advisors in oncology drug development and regulation from a global perspective. DESIGN: Recently, representatives from the United States Food and Drug Administration, European Medicines Agency, the Japanese Pharmaceuticals and Medical Devices Agency, the Australian Therapeutic Goods Administration and Health Canada held a meeting in conjunction with the American Society of Clinical Oncology meeting. The role of external advisors in oncology drug development and regulation in each of these jurisdictions was presented and discussed. RESULTS: All regulatory bodies described have experience with two forms of outside expertise: advice from individual experts and advice from a group of experts assembled as an advisory group. Regulatory jurisdictions use individual experts variably. In some regions, individual experts provide advice based on knowledge and experience during the drug development phase or in the planning phase for the submission of a drug registration package. In other regions, these individuals serve as external evaluators with the primary responsibility for the review of a clinical trials package submitted for drug registration. Advisory boards have been formalized in all jurisdictions discussed. Advisory boards have a role in discussing specific applications as well as broad policy issues. A common theme is a composition of a core panel of experts with augmentation by additional expertise as needed for consideration of specific scientific questions. In all jurisdictions, advisory board recommendations are not binding on the regulatory body. CONCLUSIONS: Global oncology drug development and registration involves the use of experts by regulatory authorities. The types of experts needed, the expert's role and the transparency of the advisory process reflect the individual needs in different regions. 相似文献